Global Erythropoietin Biosimilar Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 18 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Erythropoietin Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Erythropoietin (EPO) is the major glycoprotein hormone regulator of mammalian erythropoiesis , and is produced by kidney and liver in an oxygen-dependent manner. The biological effects of EPO are mediated by the specific erythropoietin receptor (EPOR) on bone marrow erythroblasts, which transmits signals important for both proliferation and differentiation along the erythroid lineage. EPOR is a type 1 single-transmembrane cytokine receptor, and belongs to the homodimerizing subclass which functions as ligand-induced or ligand-stabilized homodimers. EPOR pre-exists as dimers which upon binding of a 34 kDa ligand erythropoietin (Epo), changes its homodimerized state. These conformational changes result in the autophosphorylation of Jak2 kinases that are pre-associated with the receptor. Erythropoietin is necessary to maintain endothelial cells and to promote tumor angiogenesis, hence the dysregulation of EpoR may affect the growth of certain tumors. EpoR signaling prevents neuronal death and ischemic injury.

This report studies the global Erythropoietin Biosimilar production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Erythropoietin Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Erythropoietin Biosimilar that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Erythropoietin Biosimilar total production and demand, 2018-2029, (K Units)
Global Erythropoietin Biosimilar total production value, 2018-2029, (USD Million)
Global Erythropoietin Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Erythropoietin Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Erythropoietin Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Erythropoietin Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Erythropoietin Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Erythropoietin Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Erythropoietin Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, VHB Life Sciences, Chengdu Di'Ao Pharmaceutical Group, Chalver Laboratorios, Fresenius Kabi, Neiss Labs, Micro Labs, Zuventus Healthcare and RPG Life Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Erythropoietin Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Erythropoietin Biosimilar Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Erythropoietin Biosimilar Market, Segmentation by Type
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

Global Erythropoietin Biosimilar Market, Segmentation by Application
    Hematology
    Kidney Disorder
    Cancer
    Others

Companies Profiled:
    Pfizer
    VHB Life Sciences
    Chengdu Di'Ao Pharmaceutical Group
    Chalver Laboratorios
    Fresenius Kabi
    Neiss Labs
    Micro Labs
    Zuventus Healthcare
    RPG Life Sciences
    Unilab
    Incepta Pharmaceuticals
    Genius Biotherapeutics

Key Questions Answered
1. How big is the global Erythropoietin Biosimilar market?
2. What is the demand of the global Erythropoietin Biosimilar market?
3. What is the year over year growth of the global Erythropoietin Biosimilar market?
4. What is the production and production value of the global Erythropoietin Biosimilar market?
5. Who are the key producers in the global Erythropoietin Biosimilar market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Erythropoietin Biosimilar Introduction
    1.2 World Erythropoietin Biosimilar Supply & Forecast
        1.2.1 World Erythropoietin Biosimilar Production Value (2018 & 2022 & 2029)
        1.2.2 World Erythropoietin Biosimilar Production (2018-2029)
        1.2.3 World Erythropoietin Biosimilar Pricing Trends (2018-2029)
    1.3 World Erythropoietin Biosimilar Production by Region (Based on Production Site)
        1.3.1 World Erythropoietin Biosimilar Production Value by Region (2018-2029)
        1.3.2 World Erythropoietin Biosimilar Production by Region (2018-2029)
        1.3.3 World Erythropoietin Biosimilar Average Price by Region (2018-2029)
        1.3.4 North America Erythropoietin Biosimilar Production (2018-2029)
        1.3.5 Europe Erythropoietin Biosimilar Production (2018-2029)
        1.3.6 China Erythropoietin Biosimilar Production (2018-2029)
        1.3.7 Japan Erythropoietin Biosimilar Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Erythropoietin Biosimilar Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Erythropoietin Biosimilar Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Erythropoietin Biosimilar Demand (2018-2029)
    2.2 World Erythropoietin Biosimilar Consumption by Region
        2.2.1 World Erythropoietin Biosimilar Consumption by Region (2018-2023)
        2.2.2 World Erythropoietin Biosimilar Consumption Forecast by Region (2024-2029)
    2.3 United States Erythropoietin Biosimilar Consumption (2018-2029)
    2.4 China Erythropoietin Biosimilar Consumption (2018-2029)
    2.5 Europe Erythropoietin Biosimilar Consumption (2018-2029)
    2.6 Japan Erythropoietin Biosimilar Consumption (2018-2029)
    2.7 South Korea Erythropoietin Biosimilar Consumption (2018-2029)
    2.8 ASEAN Erythropoietin Biosimilar Consumption (2018-2029)
    2.9 India Erythropoietin Biosimilar Consumption (2018-2029)

3 World Erythropoietin Biosimilar Manufacturers Competitive Analysis
    3.1 World Erythropoietin Biosimilar Production Value by Manufacturer (2018-2023)
    3.2 World Erythropoietin Biosimilar Production by Manufacturer (2018-2023)
    3.3 World Erythropoietin Biosimilar Average Price by Manufacturer (2018-2023)
    3.4 Erythropoietin Biosimilar Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Erythropoietin Biosimilar Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Erythropoietin Biosimilar in 2022
        3.5.3 Global Concentration Ratios (CR8) for Erythropoietin Biosimilar in 2022
    3.6 Erythropoietin Biosimilar Market: Overall Company Footprint Analysis
        3.6.1 Erythropoietin Biosimilar Market: Region Footprint
        3.6.2 Erythropoietin Biosimilar Market: Company Product Type Footprint
        3.6.3 Erythropoietin Biosimilar Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Erythropoietin Biosimilar Production Value Comparison
        4.1.1 United States VS China: Erythropoietin Biosimilar Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Erythropoietin Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Erythropoietin Biosimilar Production Comparison
        4.2.1 United States VS China: Erythropoietin Biosimilar Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Erythropoietin Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Erythropoietin Biosimilar Consumption Comparison
        4.3.1 United States VS China: Erythropoietin Biosimilar Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Erythropoietin Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Erythropoietin Biosimilar Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Erythropoietin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Erythropoietin Biosimilar Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Erythropoietin Biosimilar Production (2018-2023)
    4.5 China Based Erythropoietin Biosimilar Manufacturers and Market Share
        4.5.1 China Based Erythropoietin Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Erythropoietin Biosimilar Production Value (2018-2023)
        4.5.3 China Based Manufacturers Erythropoietin Biosimilar Production (2018-2023)
    4.6 Rest of World Based Erythropoietin Biosimilar Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Erythropoietin Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Erythropoietin Biosimilar Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Erythropoietin Biosimilar Production (2018-2023)

5 Market Analysis by Type
    5.1 World Erythropoietin Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Hospital Pharmacy
        5.2.2 Retail Pharmacy
        5.2.3 Online Pharmacy
    5.3 Market Segment by Type
        5.3.1 World Erythropoietin Biosimilar Production by Type (2018-2029)
        5.3.2 World Erythropoietin Biosimilar Production Value by Type (2018-2029)
        5.3.3 World Erythropoietin Biosimilar Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Erythropoietin Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hematology
        6.2.2 Kidney Disorder
        6.2.3 Cancer
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Erythropoietin Biosimilar Production by Application (2018-2029)
        6.3.2 World Erythropoietin Biosimilar Production Value by Application (2018-2029)
        6.3.3 World Erythropoietin Biosimilar Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Erythropoietin Biosimilar Product and Services
        7.1.4 Pfizer Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 VHB Life Sciences
        7.2.1 VHB Life Sciences Details
        7.2.2 VHB Life Sciences Major Business
        7.2.3 VHB Life Sciences Erythropoietin Biosimilar Product and Services
        7.2.4 VHB Life Sciences Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 VHB Life Sciences Recent Developments/Updates
        7.2.6 VHB Life Sciences Competitive Strengths & Weaknesses
    7.3 Chengdu Di'Ao Pharmaceutical Group
        7.3.1 Chengdu Di'Ao Pharmaceutical Group Details
        7.3.2 Chengdu Di'Ao Pharmaceutical Group Major Business
        7.3.3 Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Product and Services
        7.3.4 Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Chengdu Di'Ao Pharmaceutical Group Recent Developments/Updates
        7.3.6 Chengdu Di'Ao Pharmaceutical Group Competitive Strengths & Weaknesses
    7.4 Chalver Laboratorios
        7.4.1 Chalver Laboratorios Details
        7.4.2 Chalver Laboratorios Major Business
        7.4.3 Chalver Laboratorios Erythropoietin Biosimilar Product and Services
        7.4.4 Chalver Laboratorios Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Chalver Laboratorios Recent Developments/Updates
        7.4.6 Chalver Laboratorios Competitive Strengths & Weaknesses
    7.5 Fresenius Kabi
        7.5.1 Fresenius Kabi Details
        7.5.2 Fresenius Kabi Major Business
        7.5.3 Fresenius Kabi Erythropoietin Biosimilar Product and Services
        7.5.4 Fresenius Kabi Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Fresenius Kabi Recent Developments/Updates
        7.5.6 Fresenius Kabi Competitive Strengths & Weaknesses
    7.6 Neiss Labs
        7.6.1 Neiss Labs Details
        7.6.2 Neiss Labs Major Business
        7.6.3 Neiss Labs Erythropoietin Biosimilar Product and Services
        7.6.4 Neiss Labs Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Neiss Labs Recent Developments/Updates
        7.6.6 Neiss Labs Competitive Strengths & Weaknesses
    7.7 Micro Labs
        7.7.1 Micro Labs Details
        7.7.2 Micro Labs Major Business
        7.7.3 Micro Labs Erythropoietin Biosimilar Product and Services
        7.7.4 Micro Labs Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Micro Labs Recent Developments/Updates
        7.7.6 Micro Labs Competitive Strengths & Weaknesses
    7.8 Zuventus Healthcare
        7.8.1 Zuventus Healthcare Details
        7.8.2 Zuventus Healthcare Major Business
        7.8.3 Zuventus Healthcare Erythropoietin Biosimilar Product and Services
        7.8.4 Zuventus Healthcare Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Zuventus Healthcare Recent Developments/Updates
        7.8.6 Zuventus Healthcare Competitive Strengths & Weaknesses
    7.9 RPG Life Sciences
        7.9.1 RPG Life Sciences Details
        7.9.2 RPG Life Sciences Major Business
        7.9.3 RPG Life Sciences Erythropoietin Biosimilar Product and Services
        7.9.4 RPG Life Sciences Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 RPG Life Sciences Recent Developments/Updates
        7.9.6 RPG Life Sciences Competitive Strengths & Weaknesses
    7.10 Unilab
        7.10.1 Unilab Details
        7.10.2 Unilab Major Business
        7.10.3 Unilab Erythropoietin Biosimilar Product and Services
        7.10.4 Unilab Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Unilab Recent Developments/Updates
        7.10.6 Unilab Competitive Strengths & Weaknesses
    7.11 Incepta Pharmaceuticals
        7.11.1 Incepta Pharmaceuticals Details
        7.11.2 Incepta Pharmaceuticals Major Business
        7.11.3 Incepta Pharmaceuticals Erythropoietin Biosimilar Product and Services
        7.11.4 Incepta Pharmaceuticals Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Incepta Pharmaceuticals Recent Developments/Updates
        7.11.6 Incepta Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Genius Biotherapeutics
        7.12.1 Genius Biotherapeutics Details
        7.12.2 Genius Biotherapeutics Major Business
        7.12.3 Genius Biotherapeutics Erythropoietin Biosimilar Product and Services
        7.12.4 Genius Biotherapeutics Erythropoietin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Genius Biotherapeutics Recent Developments/Updates
        7.12.6 Genius Biotherapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Erythropoietin Biosimilar Industry Chain
    8.2 Erythropoietin Biosimilar Upstream Analysis
        8.2.1 Erythropoietin Biosimilar Core Raw Materials
        8.2.2 Main Manufacturers of Erythropoietin Biosimilar Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Erythropoietin Biosimilar Production Mode
    8.6 Erythropoietin Biosimilar Procurement Model
    8.7 Erythropoietin Biosimilar Industry Sales Model and Sales Channels
        8.7.1 Erythropoietin Biosimilar Sales Model
        8.7.2 Erythropoietin Biosimilar Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Erythropoietin Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Erythropoietin Biosimilar Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Erythropoietin Biosimilar Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Erythropoietin Biosimilar Production Value Market Share by Region (2018-2023)
    Table 5. World Erythropoietin Biosimilar Production Value Market Share by Region (2024-2029)
    Table 6. World Erythropoietin Biosimilar Production by Region (2018-2023) & (K Units)
    Table 7. World Erythropoietin Biosimilar Production by Region (2024-2029) & (K Units)
    Table 8. World Erythropoietin Biosimilar Production Market Share by Region (2018-2023)
    Table 9. World Erythropoietin Biosimilar Production Market Share by Region (2024-2029)
    Table 10. World Erythropoietin Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Erythropoietin Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Erythropoietin Biosimilar Major Market Trends
    Table 13. World Erythropoietin Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Erythropoietin Biosimilar Consumption by Region (2018-2023) & (K Units)
    Table 15. World Erythropoietin Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Erythropoietin Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Erythropoietin Biosimilar Producers in 2022
    Table 18. World Erythropoietin Biosimilar Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Erythropoietin Biosimilar Producers in 2022
    Table 20. World Erythropoietin Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Erythropoietin Biosimilar Company Evaluation Quadrant
    Table 22. World Erythropoietin Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Erythropoietin Biosimilar Production Site of Key Manufacturer
    Table 24. Erythropoietin Biosimilar Market: Company Product Type Footprint
    Table 25. Erythropoietin Biosimilar Market: Company Product Application Footprint
    Table 26. Erythropoietin Biosimilar Competitive Factors
    Table 27. Erythropoietin Biosimilar New Entrant and Capacity Expansion Plans
    Table 28. Erythropoietin Biosimilar Mergers & Acquisitions Activity
    Table 29. United States VS China Erythropoietin Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Erythropoietin Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Erythropoietin Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Erythropoietin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Erythropoietin Biosimilar Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Erythropoietin Biosimilar Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Erythropoietin Biosimilar Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Erythropoietin Biosimilar Production Market Share (2018-2023)
    Table 37. China Based Erythropoietin Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Erythropoietin Biosimilar Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Erythropoietin Biosimilar Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Erythropoietin Biosimilar Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Erythropoietin Biosimilar Production Market Share (2018-2023)
    Table 42. Rest of World Based Erythropoietin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Erythropoietin Biosimilar Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Erythropoietin Biosimilar Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Erythropoietin Biosimilar Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Erythropoietin Biosimilar Production Market Share (2018-2023)
    Table 47. World Erythropoietin Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Erythropoietin Biosimilar Production by Type (2018-2023) & (K Units)
    Table 49. World Erythropoietin Biosimilar Production by Type (2024-2029) & (K Units)
    Table 50. World Erythropoietin Biosimilar Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Erythropoietin Biosimilar Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Erythropoietin Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Erythropoietin Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Erythropoietin Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Erythropoietin Biosimilar Production by Application (2018-2023) & (K Units)
    Table 56. World Erythropoietin Biosimilar Production by Application (2024-2029) & (K Units)
    Table 57. World Erythropoietin Biosimilar Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Erythropoietin Biosimilar Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Erythropoietin Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Erythropoietin Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 62. Pfizer Major Business
    Table 63. Pfizer Erythropoietin Biosimilar Product and Services
    Table 64. Pfizer Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Pfizer Recent Developments/Updates
    Table 66. Pfizer Competitive Strengths & Weaknesses
    Table 67. VHB Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 68. VHB Life Sciences Major Business
    Table 69. VHB Life Sciences Erythropoietin Biosimilar Product and Services
    Table 70. VHB Life Sciences Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. VHB Life Sciences Recent Developments/Updates
    Table 72. VHB Life Sciences Competitive Strengths & Weaknesses
    Table 73. Chengdu Di'Ao Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 74. Chengdu Di'Ao Pharmaceutical Group Major Business
    Table 75. Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Product and Services
    Table 76. Chengdu Di'Ao Pharmaceutical Group Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Chengdu Di'Ao Pharmaceutical Group Recent Developments/Updates
    Table 78. Chengdu Di'Ao Pharmaceutical Group Competitive Strengths & Weaknesses
    Table 79. Chalver Laboratorios Basic Information, Manufacturing Base and Competitors
    Table 80. Chalver Laboratorios Major Business
    Table 81. Chalver Laboratorios Erythropoietin Biosimilar Product and Services
    Table 82. Chalver Laboratorios Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Chalver Laboratorios Recent Developments/Updates
    Table 84. Chalver Laboratorios Competitive Strengths & Weaknesses
    Table 85. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 86. Fresenius Kabi Major Business
    Table 87. Fresenius Kabi Erythropoietin Biosimilar Product and Services
    Table 88. Fresenius Kabi Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Fresenius Kabi Recent Developments/Updates
    Table 90. Fresenius Kabi Competitive Strengths & Weaknesses
    Table 91. Neiss Labs Basic Information, Manufacturing Base and Competitors
    Table 92. Neiss Labs Major Business
    Table 93. Neiss Labs Erythropoietin Biosimilar Product and Services
    Table 94. Neiss Labs Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Neiss Labs Recent Developments/Updates
    Table 96. Neiss Labs Competitive Strengths & Weaknesses
    Table 97. Micro Labs Basic Information, Manufacturing Base and Competitors
    Table 98. Micro Labs Major Business
    Table 99. Micro Labs Erythropoietin Biosimilar Product and Services
    Table 100. Micro Labs Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Micro Labs Recent Developments/Updates
    Table 102. Micro Labs Competitive Strengths & Weaknesses
    Table 103. Zuventus Healthcare Basic Information, Manufacturing Base and Competitors
    Table 104. Zuventus Healthcare Major Business
    Table 105. Zuventus Healthcare Erythropoietin Biosimilar Product and Services
    Table 106. Zuventus Healthcare Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Zuventus Healthcare Recent Developments/Updates
    Table 108. Zuventus Healthcare Competitive Strengths & Weaknesses
    Table 109. RPG Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 110. RPG Life Sciences Major Business
    Table 111. RPG Life Sciences Erythropoietin Biosimilar Product and Services
    Table 112. RPG Life Sciences Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. RPG Life Sciences Recent Developments/Updates
    Table 114. RPG Life Sciences Competitive Strengths & Weaknesses
    Table 115. Unilab Basic Information, Manufacturing Base and Competitors
    Table 116. Unilab Major Business
    Table 117. Unilab Erythropoietin Biosimilar Product and Services
    Table 118. Unilab Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Unilab Recent Developments/Updates
    Table 120. Unilab Competitive Strengths & Weaknesses
    Table 121. Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 122. Incepta Pharmaceuticals Major Business
    Table 123. Incepta Pharmaceuticals Erythropoietin Biosimilar Product and Services
    Table 124. Incepta Pharmaceuticals Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Incepta Pharmaceuticals Recent Developments/Updates
    Table 126. Genius Biotherapeutics Basic Information, Manufacturing Base and Competitors
    Table 127. Genius Biotherapeutics Major Business
    Table 128. Genius Biotherapeutics Erythropoietin Biosimilar Product and Services
    Table 129. Genius Biotherapeutics Erythropoietin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Erythropoietin Biosimilar Upstream (Raw Materials)
    Table 131. Erythropoietin Biosimilar Typical Customers
    Table 132. Erythropoietin Biosimilar Typical Distributors
List of Figure
    Figure 1. Erythropoietin Biosimilar Picture
    Figure 2. World Erythropoietin Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Erythropoietin Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Erythropoietin Biosimilar Production (2018-2029) & (K Units)
    Figure 5. World Erythropoietin Biosimilar Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Erythropoietin Biosimilar Production Value Market Share by Region (2018-2029)
    Figure 7. World Erythropoietin Biosimilar Production Market Share by Region (2018-2029)
    Figure 8. North America Erythropoietin Biosimilar Production (2018-2029) & (K Units)
    Figure 9. Europe Erythropoietin Biosimilar Production (2018-2029) & (K Units)
    Figure 10. China Erythropoietin Biosimilar Production (2018-2029) & (K Units)
    Figure 11. Japan Erythropoietin Biosimilar Production (2018-2029) & (K Units)
    Figure 12. Erythropoietin Biosimilar Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 15. World Erythropoietin Biosimilar Consumption Market Share by Region (2018-2029)
    Figure 16. United States Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 17. China Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 18. Europe Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 19. Japan Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 22. India Erythropoietin Biosimilar Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Erythropoietin Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Erythropoietin Biosimilar Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Erythropoietin Biosimilar Markets in 2022
    Figure 26. United States VS China: Erythropoietin Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Erythropoietin Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Erythropoietin Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Erythropoietin Biosimilar Production Market Share 2022
    Figure 30. China Based Manufacturers Erythropoietin Biosimilar Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Erythropoietin Biosimilar Production Market Share 2022
    Figure 32. World Erythropoietin Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Erythropoietin Biosimilar Production Value Market Share by Type in 2022
    Figure 34. Hospital Pharmacy
    Figure 35. Retail Pharmacy
    Figure 36. Online Pharmacy
    Figure 37. World Erythropoietin Biosimilar Production Market Share by Type (2018-2029)
    Figure 38. World Erythropoietin Biosimilar Production Value Market Share by Type (2018-2029)
    Figure 39. World Erythropoietin Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Erythropoietin Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Erythropoietin Biosimilar Production Value Market Share by Application in 2022
    Figure 42. Hematology
    Figure 43. Kidney Disorder
    Figure 44. Cancer
    Figure 45. Others
    Figure 46. World Erythropoietin Biosimilar Production Market Share by Application (2018-2029)
    Figure 47. World Erythropoietin Biosimilar Production Value Market Share by Application (2018-2029)
    Figure 48. World Erythropoietin Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Erythropoietin Biosimilar Industry Chain
    Figure 50. Erythropoietin Biosimilar Procurement Model
    Figure 51. Erythropoietin Biosimilar Sales Model
    Figure 52. Erythropoietin Biosimilar Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Erythropoietin Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Erythropoietin Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Erythropoietin Biosimilar market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Erythropoietin Biosimilar Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Erythropoietin Biosimilar Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Erythropoietin Biosimilar market size was valued at USD 1395.3 million in 2023 and is forecast to a readjusted size of USD 2102 million by 2030 with a CAGR of 6.0% during review period.

Global Erythropoietin Biosimilar Supply, Demand and Key Producers, 2024-2030

Global Erythropoietin Biosimilar Supply, Demand and Key Producers, 2024-2030

date 15 Feb 2024

date Pharma & Healthcare

The global Erythropoietin Biosimilar market size is expected to reach $ 2102 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).

Product Tags

Erythropoietin Biosimilar

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>